Search Results - "Luksch R"

This result is not displayed to guests.
Login for full access.

Stage 4 neuroblastoma: sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment.

Authors: Luksch, R. Podda, M. Gandola, L. et al.

Source: British Journal of Cancer. 6/6/2005, Vol. 92 Issue 11, p1984-1988. 5p.

Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.

Authors: Luksch, R. Tienghi, A. Hall, K. Sundby et al.

Source: Annals of Oncology. Nov2012, Vol. 23 Issue 11, p2970-2976. 7p. 2 Diagrams, 3 Charts, 1 Graph.

Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.

Authors: Luksch R Grignani G Fagioli F et al.

Source: European Journal of Cancer. Mar2007, Vol. 43 Issue 5, p885-890. 6p.

A MULTIDISCIPLINARY APPROACH FOR AUTOLOGOUS PBSC LEUKAPHERESIS IN PRESCHOOL AGE PATIENTS WITH SOLID TUMORS.

Authors: Alcamo, S. .Albasini, R .Dentella, M et al.

Source: Transfusion & Apheresis Science. Feb2026, Vol. 65 Issue 1, pN.PAG-N.PAG. 1p.

Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol.

Authors: Ferrari, S. Sundby Hall, K. Luksch, R. et al.

Source: Annals of Oncology. May2011, Vol. 22 Issue 5, p1221-1227. 7p. 1 Diagram, 4 Charts, 1 Graph.

Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients.

Authors: Palmerini, E. Jones, R. L. Setola, E. et al.

Source: Acta Oncologica. 2018, Vol. 57 Issue 7, p958-964. 7p. 1 Diagram, 7 Charts, 1 Graph.

Poor prognosis osteosarcoma: new therapeutic approach.

Authors: Fagioli, F. Biasin, E. Mereuta, O. M et al.

Source: Bone Marrow Transplantation. Jun2008 Supplement, Vol. 41, pS131-S134. 4p. 1 Black and White Photograph, 2 Diagrams.

Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience.

Authors: Berlanga, P. Pasqualini, C. Pötschger, U. et al.

Source: European Journal of Cancer. Feb2021, Vol. 144, p1-8. 8p.

Two-stage phase II study of imatinib mesylate in subjects with refractory or relapsing neuroblastoma.

Authors: Calafiore, L. Amoroso, L. Della Casa Alberighi, O. et al.

Source: Annals of Oncology. May2013, Vol. 24 Issue 5, p1406-1413. 8p.

Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: The Italian Sarcoma Group Experience (1983-2006)

Authors: Longhi A Ferrari S Tamburini A et al.

Source: Cancer (0008543X). Oct2012, Vol. 118 Issue 20, p5050-5059. 10p.

PV-0364 Pulmonary function after high dose chemotherapy + total lung irradiation for pediatric Ewing sarcoma.

Authors: Diletto, B. Pecori, E. Puma, N. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS180-S181. 2p.

1625MO ABCB1/P-glycoprotein (Pgp) expression as stratification factor for treatment of patients with non metastatic extremity high grade osteosarcoma: An Italian Sarcoma Group (ISG) multicentric prospective trial (ISG/OS-2).

Authors: Palmerini, E. Meazza, C. Tamburini, A. et al.

Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS976-S976. 1p.

SP-0179 UPDATE ON NEUROBLASTOMA

Authors: Gandola, L. Pecori, E. Pignoli, E. et al.

Source: Radiotherapy & Oncology. May2012 Supplement, Vol. 103 Issue s1, pS68-S69. 0p.

Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track?

Authors: Onesti CE Casini B De Chiara A et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jun 03; Vol. 16, pp. 1641281. Date of Electronic Publication: 2026 Jun 03 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Dinutuximab beta versus historical controls in the treatment of relapsed neuroblastoma: unadjusted and adjusted indirect comparisons.

Authors: Lode HN Holko P Wieczorek A et al.

Source: Frontiers in oncology [Front Oncol] 2026 Jan 22; Vol. 15, pp. 1736165. Date of Electronic Publication: 2026 Jan 22 (Print Publication: 2025).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Management of atypical cartilaginous tumors (ACT): an Italian Sarcoma Group (ISG) consensus document.

Authors: Campanacci DA Baldi GG Scanferla R et al.

Corporate Authors: Campanacci DA Baldi GG Scanferla R et al.

Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Jul; Vol. 223, pp. 105358. Date of Electronic Publication: 2026 May 06.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE; In Process

Corrigendum to "Management of atypical cartilaginous tumors (ACT): An Italian Sarcoma Group (ISG) consensus document" [Crit. Rev. Oncol. Hematol. 223 (2026) 105358].

Authors: Campanacci DA Bald GG Scanferla R et al.

Corporate Authors: Campanacci DA Bald GG Scanferla R et al.

Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Jun 27, pp. 105460. Date of Electronic Publication: 2026 Jun 27.

Publication Type: Published Erratum

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE

Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Authors: Tirtei E Difilippo V Divincenzo F et al.

Source: Cancer research communications [Cancer Res Commun] 2026 Apr 01; Vol. 6 (4), pp. 857-872.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Authors: Luksch R Palmerini E Milano GM et al.

Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2025 Apr; Vol. 72 (4), pp. e31551. Date of Electronic Publication: 2025 Jan 20.

Publication Type: Clinical Trial, Phase III; Equivalence Trial; Journal Article; Multicenter Study; Randomized Controlled Trial

Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE